Commonwealth Equity Services
GYRE icon

Commonwealth Equity Services’s Gyre Therapeutics GYRE Stock Holding History

Commonwealth Equity Services’s Portfolio GYRE Stock Details GYRE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-5,402
Closed -$20K – 3744
2022
Q3 		$20K Buy
5,402
+4,069
+305% +$51.7K ﹤0.01% 3581
2022
Q2 		$17K Hold
1,333
– – ﹤0.01% 3583
2022
Q1 		$6K Hold
1,333
– – ﹤0.01% 3696
2021
Q4 		$9K Hold
1,333
– – ﹤0.01% 3633
2021
Q3 		$41K Buy
+1,333
New +$43.9K ﹤0.01% 3509

Other funds holding GYRE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

Commonwealth Equity Services's GYRE Position: Q4 2022 in Review

Commonwealth Equity Services sold out of Gyre Therapeutics (GYRE) in Q4 2022, closing a stake of 5,402 shares — an estimated $20K sold.

Commonwealth Equity Services first reported a position in GYRE in Q3 2021 and held it in 5 quarters. The position peaked at $41K in Q3 2021. 34 funds tracked by Wall St. Rank hold GYRE as of Q4 2022.

  • Commonwealth Equity Services reported no remaining Gyre Therapeutics position as of Q4 2022 after selling out during the quarter.
  • Commonwealth Equity Services sold 5,402 Gyre Therapeutics shares in Q4 2022, an estimated $20K.
  • Commonwealth Equity Services first reported a position in Gyre Therapeutics in Q3 2021 and held it in 5 quarters.
  • Commonwealth Equity Services's Gyre Therapeutics position peaked at $41K in Q3 2021.
  • 34 funds tracked by Wall St. Rank held Gyre Therapeutics as of Q4 2022.

Based on Commonwealth Equity Services's 13F filing for Q4 2022, filed 7 Feb 2023.